CERo Therapeutics Holdings, Inc.
CERO
$0.8899
-$0.0579-6.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 153.11% | -183.07% | -17.02% | 5.68% | -381.61% |
| Total Depreciation and Amortization | -0.07% | 5.65% | 5.69% | 5.34% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,593.39% | 264.47% | -775.37% | -3,438.27% | 109.58% |
| Change in Net Operating Assets | 1,051.96% | 2,082.82% | 1,723.66% | -236.50% | -108.95% |
| Cash from Operations | -60.29% | -109.25% | -70.53% | -253.60% | -157.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -107.65% |
| Total Debt Issued | -- | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | -348.30% | -266.26% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 108,892.00% | 163.46% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5,023.90% | -6,281.21% | 133.25% | -- | -- |
| Cash from Financing | -- | -- | 357.41% | 137,550.00% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.47% | 79.76% | 37.25% | 245.14% | -102.31% |